PPT-Drug-eluting coronary stent market overview

Zach Eddy Category Advisor 2 What are drugeluting coronary stents Design Expandable wire mesh tube Coated with an antiproliferative drug Premounted on a balloon catheter delivery system Function. , . and Bio-. Absorbables. . John Wainwright, Ph.D.. Sr. R&D . Manager, Medtronic plc. WLNC 06/08/15. Some of the technologies/devices discussed in this talk are not approved in the US . Reasons for Coatings and Surface Modifications. resténose. . intra-stent. au ballon actif. Peeper. Pre-procedure. Post-procedure. 6-month. In-stent. Reference. vessel diameter. 2.84 ± 0.39mm. 2.86 ± 0.39mm. 2.82 ± 0.38mm. Minimum lumen diameter. Dalby. , Munich, ESC2008. Update about the OCT data of the . Translumina. DES and competitors. A . Randomised. . optical. . coherence. . tomography. . study. . to. . determine. 90 . day. . stent. January 15. th. , 2016. 10h30. What is/are the best antithrombotic treatment(s) in case of stent thrombosis?. A. ). . 75mg . of . clopidogrel. B). 150mg . of . clopidogrel. C). 90mg x 2 . of . ticagrelor. , . and Bio-. Absorbables. . John Wainwright, Ph.D.. Sr. R&D . Manager, Medtronic plc. WLNC 06/08/15. Some of the technologies/devices discussed in this talk are not approved in the US . Reasons for Coatings and Surface Modifications. Second Generation Drug-eluting Stents Using. Either Biodegradable Polymer or Durable Polymer. The NOBORI . Biolimus. -Eluting versus . XIENCE/PROMUS . Everolimus. -eluting Stent Trial (NEXT). Masahiro . J. Hausleiter, I. Ott, M. Fusaro, T. Ibrahim, A. Schömig,. . A. Kastrati. . Deutsches Herzzentrum & 1st Med. Klinik rechts der Isar,. Technische Universität Munich,. Germany. ISAR-CABG:. Randomized, Superiority Trial of . vs. 1.46 mm, . p < 0.0001; . IVUS showed lower post-procedure mean lumen area in BVS arm (4.9 vs. 5.7 mm. 2. , . p < 0.001. ). 1-year scaffold thrombosis in . two . BVS . patients; . no stent thrombosis in DES arm. b. A. lloon. for in-stent . Re. stenosis). José PS Henriques, MD. Jan Baan, MD. Academic Medical Center . Amsterdam, The Netherlands. A randomized comparison of paclitaxel-eluting balloon* versus . Fig. 1.Initial, postprocedural and followup angiograms of case 1. A instent restenosis of the bare metal stent in the proximal left anterior descen - ding artery. B postprocedural angiogram after perf fact, the first BP stentwas made of polyesters. Poly(orthoesters), polyanhydrides, and polyphosphazenes are alsobeing actively investigated.DEGRADATION OF POLYMERSDegradation of polymers generally ref Bioresorbable. Polymer-Based Drug-Eluting Stent in an All-Comers Patient Population. Lisette Okkels Jensen, Michael . Maeng. , Bent . Raungaard. , Johnny . Kahlert. , Julia Ellert, Lars . Jakobsen. , . : The. . HOST. -Reduce-. Polytech. -. ACS. . trial. Hyo-Soo Kim, MD/PhD. Cardiovascular Center,. Seoul National University Hospital, Korea. Session of Late Breaking Trial Session IV. Co-sponsored by European Heart Journal. Present and Future. Taehoon. . Ahn. , MD, PhD, FSCAI, FACC. Gachon. University Gil Medical Center . Incheon, South Korea. JCR2016. Conflict of interest: Nothing to report. Disclosure. Current situation of Korea made drug-eluting stents in Korea .